Key facts
- This page summarizes Jerome B. Zeldis's Form 4 filing for NEXGEL, INC. (NXGL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Nov 2024, 16:54.
Jerome B. Zeldis - 20 Nov 2024 Form 4 Insider Report for NEXGEL, INC. (NXGL)
- Reporting relationship
- Director
- Issuer ticker
- NXGL
- Reported as of
- 20 Nov 2024
- Net transaction value
- +$9,999
- SEC form
- 4
- Accepted by SEC
- 22 Nov 2024, 16:54:12 UTC
- Prior SEC filing
- 17 Sep 2024
- Next SEC filing
- 04 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jerome B. Zeldis
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jerome B. Zeldis filed Form 4 for NEXGEL, INC. (NXGL) on 22 Nov 2024.
Change
- Previous filing in this sequence was filed on 17 Sep 2024.
- Current net transaction value: +$9,999.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NXGL
transaction
Common Stock
Purchase
- Transaction value
- $9,999
- Shares
- +3,636
- Change %
- +3.5%
- Price
- $2.75
- Shares after
- 106,664
- Date
- 20 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NXGL
transaction
Derivative
Warrant to Purchase Common Stock
Award
- Transaction value
- $0
- Shares
- +1,818
- Change %
- Price
- $0.000000
- Shares after
- 1,818
- Date
- 20 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,818
- Exercise price
- $4.25
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The Reporting Person acquired the shares of common stock and warrant to purchase common stock reported on this Form 4 in connection with the Issuer's registered direct offering. The Reporting Person agreed not to offer, issue, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any of the shares of common stock and the shares of common stock underlying the warrant for a period of 180 days following November 20, 2024.